Minerva Neurosciences NERV
NASDAQ NERV
$3.35 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Capital Expenditures (2014)

Updated

Minerva Neurosciences (NERV) posted Capital Expenditures of $16,326 for FY2022.

Analysis

Minerva Neurosciences (NERV) Capital Expenditures (2014) Analysis & Trends

Since FY2013, Minerva Neurosciences has reported Capital Expenditures for 4 years.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of -20.8% (FY2017 to FY2022).
  • The FY2022 figure stands as the highest annual Capital Expenditures since FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Minerva Neurosciences 158.21 Mn 158.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 11,870.00
API Access

Minerva Neurosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NERV&period=max&api_key=YOUR_API_KEY